The immune system provides a highly sophisticated surveillance mechanism to detect diverse antigens and to protect the host organism from invading pathogens and altered cells (e.g., virus-infected and tumor cells). Adaptive immune responses depend on the recognition of antigen by specific antigen receptors that are expressed on the surface of T and B lymphocytes. Helper T cells provide regulatory functions and direct the adaptive immune system to respond appropriately to a particular antigen (i.e., cytotoxic T cell responses against viral infections and tumor cells, humoral responses against extracellular bacteria and parasitic worms). Helper T cells express CD4 coreceptors, which recognize conserved domains on proteins expressed by the class II major histocompatibility complex, the same proteins that present antigen to the T cell receptor. Recent progress in T cell biology has identified multiple regulatory functions of CD4 during thymocyte development and antigen stimulation of mature T helper cells. Signaling pathways induced by engagement of CD4 independently of T cell receptor signaling mediate these regulatory functions. In this review, we discuss the regulation of T cell signaling and emphasize the functional consequences of proper and improper CD4 coreceptor signaling.
Introduction
The immune system provides a highly sophisticated surveillance mechanism to detect diverse antigens and protect the host organism from invading pathogens and altered cells (e.g., virus-infected and tumor cells). Adaptive immune responses depend on the recognition of antigens by specific antigen receptors expressed on the surface of T and B lymphocytes. To initiate effector mechanisms, antigen recognition must induce intracellular signaling cascades that activate the lymphocyte and promote the differentiation to an effector cell appropriate for the particular antigenic challenge. Importantly, regulatory mechanisms must also be present to safeguard against inadvertent self-reactivity, which could lead to autoimmunity, and to terminate immune responses, thus avoiding overexposure of the organism to toxic effectors (e.g., cytotoxic T cells, cytokines).
T lymphocytes are derived from the lymphoid lineage of hematopoietic stem cells. T cell progenitors enter the thymus where they develop into mature T lymphocytes (Res and Spits, 1999) . During thymic development, the immature thymocytes undergo rearrangement of first the β and then the α T cell receptor (TCR) genes (Khor and Sleckman, 2002; Raulet et al., 1985) . This process increases the diversity of available TCRs and assures that each T cell expresses only a single type of TCR. Only those thymocytes that have successfully completed TCR gene rearrangement will be allowed to survive. Unsuccessful rearrangement leads to programmed cell death by apoptosis.
Following rearrangement, the functionality of the maturing thymocytes is tested by interactions with thymic antigen-presenting cells (APCs). In order to be functional, the thymocytes' TCR must be able to engage epitopes formed by short peptides bound to molecules encoded by the major histocompatibility complex (MHC). Because of the large isotypic and allelic variability of MHC molecules within each species, not all recombination events of TCR genes lead to matches with a peptide/MHC complex potentially present in the individual organism. Therefore, a positive selection event is required. Two classes of MHC molecules select T cells with different functions. MHC class I molecules bind peptides derived from proteins synthesized by the presenting cell and proteolytically processed by the cell's proteasome (Niedermann, 2002) . These peptides can combine with nascent MHC class I molecules in the endoplasmic reticulum (Norbury et al., 2001; Yewdell, 2001) . MHC class II molecules bind peptides derived from extracellular, endocytosed proteins that are processed in lysosomes. Nascent and recycling MHC class II molecules bind these peptides while trafficking through lysosomes (Germain, 1994) .
Positive selection of thymocytes requires that the interactions between the TCR and peptide/MHC complexes induce signals of sufficient strength and duration (Hogquist, 2001) . Thymocytes that do not receive a TCR-mediated signal during positive selection die. Positive selection occurs on thymic stromal epithelial cells (Capone et al., 2001; Chidgey and Boyd, 2001 ), which do not present a full complement of all possible antigens that the T cell might encounter during its lifetime. Thus, selected T cells have partial self-reactivity and the potential to recognize antigens 2 König and Zhou that will only be encountered later in life. The mechanisms and models of positive selection have been recently reviewed (Germain, 2002; Singer, 2002) .
Maturing thymocytes express both CD4 and CD8 coreceptors. Following positive selection, one coreceptor gene is silenced (Leung et al., 2001; Taniuchi et al., 2002; Zou et al., 2001) . Recent experimental results suggest that the duration of the selection signal determines lineage commitment with a short duration leading to differentiation to CD8 + and a long duration favoring differentiation to CD4 + thymocytes (Brugnera et al., 2000; Yasutomo et al., 2000) .
A negative selection step eliminates thymocytes that overtly respond to self-antigens. Estimates suggest that of all thymocytes that mature up to the double-positive (CD4 + CD8 + ) stage, only about 3% complete maturation and emigrate from the thymus to peripheral lymphoid tissues (e.g., blood, lymph nodes, and spleen) (Surh and Sprent, 1994) . Negative selection is mediated by thymic stromal cells or APCs (mainly dendritic cells) that migrate from peripheral organs into the thymus (Brocker, 1999) . These cells provide a large battery, but not a complete complement, of different peptides derived from self and foreign proteins. Thymocytes that vigorously respond to the stimuli presented during negative selection will undergo apoptosis (Bommhardt et al., 2000; Robey and Fowlkes, 1994; Williams et al., 1999) .
In this review, we will discuss signal transduction in CD4 + T helper (Th) cells, which regulate adaptive immune responses by promoting and directing the differentiation and activation of B cells and cytotoxic CD8 + T cells (Schoenberger et al., 1998; Snow et al., 1994) . Activation of Th cells is critical for the clearance of pathogenic infections (Diepolder et al., 1998; Taylor-Robinson and Phillips, 1992) and for the destruction of tumor cells (Kahn et al., 1991) . Th cells also participate in the pathogenesis of many autoimmune disorders (Datta et al., 1997; Rizzo et al., 1996) and in transplant rejection (Bushell et al., 1995) . Th cells recognize antigen in the context of MHC class II molecules and express the CD4 coreceptor on their cell surface, which interacts with non-polymorphic regions of MHC class II (König et al., 1992; König et al., 1995) . The binding of the antigen-specific TCR to antigen/MHC class II complexes initiates Th cell activation, but the engagement of CD4 by MHC class II regulates Th cell signaling, promoting progression in the cell cycle and expression of immune response genes.
T helper cell activation
The antigen-specific T cell receptor Following thymic selection, peripheral T lymphocytes express a TCR that is composed of two transmembrane proteins, the α and the β chains, linked by a disulfide bridge. This αβ TCR is the antigen-recognition unit of the T cell, but it does not have intrinsic signaling capability. The ability to transduce intracellular signals is conveyed to the TCR via its mandatory and constitutive association with a multiprotein structure, termed the CD3-ζ complex. None of the individual components of the TCR/CD3-ζ signaling machine can be transported to the cell surface without full assembly of the complex (Sun et al., 2001) .
The CD3 complex is composed of four transmembrane polypeptide chains, a γε and a δε heterodimer. These proteins have very short extracellular domains and each intracellular domain contains a conserved protein tyrosine kinase (PTK) recognition motif, termed "Immunoreceptor Tyrosine-based Activation Motif" (ITAM). The associated, disulfide-linked ζ-dimer, sometimes substituted by a ζ-η heterodimer, contains three ITAMs per protein chain (De Aos et al., 1997) . ITAMs are substrates for src family PTKs (Iwashima et al., 1994; Weil et al., 1995) , and their phosphorylation is a determining initiation event for T cell signaling (Qian et al., 1993) .
The binding of ligands to the TCR triggers the activation of receptor-associated src family PTKs, such as p56 lck and p59 fyn , leading to the rapid tyrosine phosphorylation of numerous proteins. The phosphorylation of ITAMs located in the cytoplasmic tails of CD3 and ζ 2 generates binding sites for proteins bearing Src homology 2 (SH2) domains such as the cytosolic syk family PTK "ζ-associated protein of 70 kDa" (ZAP-70) (Chan et al., 1991) . Recruitment of ZAP-70 allows enhanced activation of that kinase (Lograsso et al., 1996) . ZAP-70 in turn phosphorylates components of distinct downstream signaling pathways (Elder et al., 2001; Gong et al., 2001; Magnan et al., 2001) . Thus, T cell activation depends on the activation of both src family kinases and ZAP-70 (Figure 1 ).
The formation of signalosomes
The engagement of TCRs by antigen/MHC ligands induces a complex temporal and spatial arrangement of signaling complexes and networks. Slightly different compositions of these signaling machines -also termed "signalosomes" (Werlen et al., 2000) -using essentially the same components can induce different second messenger signals and lead to drastically diverse cellular responses. In addition, the dynamic assembly and disassembly of signalosomes is likely a major factor in regulating signal transduction networks. TCR signalosomes consist of transmembrane receptors, protein kinases, phosphatases and their substrates, all of which are organized into signaling machines by anchoring, adapter, and scaffolding proteins. Signalosomes connect events on the plasma membrane to distal signaling cascades, which ultimately modulate T cell biology. Several protein adapters, in particular "linker of activated T cells" (LAT), act as central switches that translate the quality, quantity, and duration of signals into the correct activation of specific downstream pathways (Zhang et al., 1998) . Although the precise parameters that regulate the formation of signalosomes still await further clarification, recent work in this area has identified some characteristics of the signalosomes.
Formation of signalosomes is aided by compartmentalization of the plasma membrane into detergent-insoluble, sphingolipid/cholesterol-enriched micro-domains, which promote the recruitment of signal transduction molecules to the TCR signaling machine upon TCR engagement (Harder and Kuhn, 2001; Leitenberg et al., 2001) . These areas of the T cell surface are also known as lipid "rafts". Palmitoylation constitutively embeds several components such as Lck, Fyn, and LAT into these lipid micro-domains, whereas others such as ZAP-70 relocalize into rafts upon TCR engagement (Harder and Kuhn, 2001; Werlen et al., 2000) .
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The relocalization of signalosomes to receptorassociated scaffolds is crucial for effective signal transduction (Delgado et al., 2000; Harder and Kuhn, 2000; Werlen et al., 2000) . Adapter proteins with SH2 domains bind to the phosphorylated ζ chain. Among these proteins is the "Src homology 2 protein of beta-cells" (Shb), which recruits LAT (Welsh et al., 1998; Zhang et al., 1998) , a substrate for . Tyrosine phosphorylation of LAT leads to the recruitment of additional signaling molecules with SH2 motifs (Figures 1 and 2 ), including the adapter "growth factor receptor-bound protein 2" (Grb2), the phospholipase Cγ1 (PLCγ1), and the p85 subunit of phosphatidylinositol 3-kinase (PI 3-kinase) (Paz et al., 2001; Sommers et al., 2001; Yablonski and Weiss, 2001; Zhang et al., 1998) .
Active PLCγ1 hydrolyzes phosphotidylinositol biphosphate (PIP 2 ), producing diacylglycerol (DAG) and 1,4,5-inositol triphosphate (IP 3 ). DAG in turn activates the serine/threonine kinase family of protein kinase C (PKC), while IP 3 induces calcium ion (Ca 2+ ) mobilization in the cytosol (Corado et al., 1990; May et al., 1986) . Thus, ZAP-70 amplifies the TCR signal by specifically phosphorylating downstream components such as LAT and PLCγ1 ( Figures  1 and 2) .
In this way, the signalosome expands in molecular complexity and amplifies the TCR initiated signal. Importantly, LAT can also bind proteins that negatively regulate TCR signaling. The "SH2 domain-containing hematopoietic phosphotyrosine phosphatase", SHP-1, associates with LAT upon TCR stimulation (Kosugi et al., 2001; Su et al., 2001) and prevents further phosphorylation of the adapter by ZAP-70, suggesting a potential conversion from an "activating" to an "inhibiting" signalosome. Similarly, the "C-terminal src kinase" (Csk) relocalizes to rafts by docking to the transmembrane adapter, Csk-binding protein (Cbp), also known as "phosphoprotein associated with glycosphingolipid-enriched microdomains" (PAG) (Brdicka et al., 2000) . In rafts, Csk inhibits src family PTKs by phosphorylating their regulatory tyrosines, and thus blocks TCR-mediated signal transduction (Vang et al., 2001 ). 
The CD4 coreceptor
The best-characterized coreceptors, and most important for the discussions presented in this review, are the membrane glycoproteins CD4 and CD8. In mature T cells, the expression of CD4 and CD8 is mutually exclusive. In general, CD4 + T cells respond to antigen presented by MHC class II molecules, and CD8 + T cells respond to MHC class I-presented antigens (Bierer et al., 1989; Swain, 1983) . Therefore, CD4 + and CD8 + T cells are considered to be restricted by MHC class II and MHC class I, respectively. Importantly, MHC class restriction is independent of the Th or cytotoxic functions displayed by mature T cells (Krensky et al., 1982; Meuer et al., 1982; Swain, 1981) . The correlation between CD4 or CD8 expression and MHC recognition results from direct interactions between the coreceptors and relatively monomorphic regions of the membrane-proximal, immunoglobulin-like domains of the MHC molecules (Connolly et al., 1990; Gao et al., 1997; Kern et al., 1998; König et al., 1992; König et al., 1995; Salter et al., 1990) . Coreceptors are associated with the TCR/CD3-ζ complex upon T cell activation. Their presence in the TCR multi-component signaling machine amplifies or modulates the activation signal. Often, their presence is absolutely required, but not sufficient, for productive signaling, i.e., signaling that results in cell cycle progression and effector functions. Interestingly, three-dimensional live cell imaging of fluorescence resonance energy transfer between CD3-ζ and CD4 demonstrates recruitment of CD4 to the CD3-ζ complex dependent on antigen-stimulation of the TCR (Zal et al., 2002) . Importantly, the antigen threshold for T cell activation is affected by the presence of CD4 in the TCR/ CD3 complex. In the presence of CD4, a single MHC class II molecule presenting antigen suffices to induce Ca 2+ flux, and 10 class II MHC/antigen complexes cause the formation of an immunological synapse (Irvine et al., 2002) . Blocking of CD4 reduces the sensitivity to antigen stimulation by more than three-fold (Irvine et al., 2002) .
The structural basis of interactions between CD4 and MHC class II molecules The proteins encoded by the class II MHC consist of two non-covalently associated integral membrane polypeptide chains, the α and the β chains (König et al., 1996) . Each polypeptide chain forms two protein domains (α1, α2, β1,and β2). The α1 and β1 domains are highly polymorphic and combine to form an antigen peptide-binding groove (Brown et al., 1988; Brown et al., 1993) . Using a combination of mutational and functional analysis, we identified amino acid residues on MHC class II molecules that mediate the interaction with CD4 (König et al., 1992; König et al., 1995) . A major CD4 binding site, forming a short loop exposed on the surface of the class II β2 domain, consists of amino acids 134-148 (Cammarota et al., 1992; König et al., 1992) . Specifically, glutamic acid 137 is mandatory for mediating the interactions with CD4, and an alanine substitution at this position alone will disrupt all T cell functions mediated by engagement of CD4 (König et al., 1992) . A second interaction site is located within the α2 domain of MHC class II (Gaubin et al., 1999; König et al., 1995) . Importantly, both sites are required for mediating interactions with CD4. We have recently reviewed the literature on interactions between MHC molecules and coreceptors of the TCR (König, 2002) .
Functional consequences of CD4 engagement by monoclonal antibodies
The crystal structure of the exodomains of human CD4 suggests that the membrane proximal domains of CD4 may promote dimerization (Wu et al., 1997) . Extraction of CD4 oligomers from freshly isolated T lymphocytes and lymphoid cell lines also indicates that oligomerization may be an intrinsic property of CD4 molecules (Lynch et al., 1999) . Many cell surface receptors transduce signals following oligomerization (Papoff et al., 1999; Rodriguez-Frade et al., 1999; White and Tartaglia, 1999) . Therefore, a common procedure to test whether CD4 can activate intracellular signaling pathways utilizes crosslinking anti-CD4 antibodies alone or in conjunction with anti-TCR antibodies (Luo and Sefton, 1990; Pallier et al., 1998; Prasad et al., 1993; Ravichandran et al., 1993; Veillette et al., 1989) . However, antibody-mediated crosslinking prevents co-localization of CD4 with TCR molecules (Ratcliffe et al., 1992) , and does not adequately reflect CD4-mediated signaling induced by engaging MHC class II during antigen activation. Ligation of CD4 by anti-CD4 antibodies or the envelope glycoprotein of the human immunodeficiency virus (HIV), gp120, inhibits antigen-dependent and -independent T cell activation (Jabado et al., 1994; Jauliac et al., 1998; Marschner et al., 2002) . The inhibition of T cell activation induced by CD4 ligation depends on the cytoplasmic domain of CD4 (Marschner et al., 2002) . Binding of these cross-linking ligands decreases the DNA-binding activity of the nuclear transcription factors NF-AT, NF-κB, and AP-1, thus preventing IL-2 synthesis (Jabado et al., 1994) . These results indicate that ligation of CD4 apart from the TCR/CD3 complex induces negative, regulatory signals that prevent the activation of nuclear factors necessary for IL-2 gene transcription and cell proliferation. Interestingly, memory CD4 + T cells appear to be more susceptible to negative signals transduced via CD4 as their activation can be prevented by both antibody-mediated CD4 ligation and MHC class II molecules on APCs in the absence of antigen (Farber et al., 1995) .
Experiments using various monoclonal anti-CD4 antibodies recognizing different epitopes suggested the existence of specific signaling epitopes on CD4 (Milia et al., 1997) . Depending on the epitope recognized by a specific monoclonal antibody, different signaling pathways are activated. Also, the simultaneous engagement of nonoverlapping CD4 epitopes can modify the signals from individual epitopes (Milia et al., 1997) . These experiments and structure-function analysis of the CD4-MHC class II interaction suggest that MHC class II molecules bind to a broad region on the membrane-distal domains of CD4 (König et al., 1996) , and induce signals via CD4 that differ from those induced by other natural CD4 ligands (e.g., gp120 and IL-16) or monoclonal antibodies. Therefore, we used a dual approach to identify CD4-mediated signals induced by MHC class II engagement. First, we separated TCR-mediated and CD4-mediated signals by restricting the ability of MHC class II to interact with CD4 during antigen stimulation (Zhou and König, 2003) . Second, we avoided antibody-mediated crosslinking, but employed a peptide mimetic to engage the CD4 epitope recognized by MHC class II (Zhou and König, 2003) . This peptide binds to CD4 + T cells (Shen et al., 1996) and soluble CD4 (Cammarota et al., 1992) .
The formation of the immunological synapse TCR-antigen/MHC interactions initiate the formation of a specialized junction between T cells and APCs, the immunological synapse (Monks et al., 1998) . Stimulationand cytoskeleton-dependent processes cluster TCR/CD3 complexes in the center of the synapse, also termed the "central zone of the supramolecular activation cluster" (cSMAC), whereas adhesion molecules such as LFA-1 form a ring surrounding the central area called the peripheral SMAC (pSMAC) (Delon and Germain, 2000; Grakoui et al., 1999) . After stimulation of the T cell, CD4 coreceptors are rapidly recruited into the cSMAC, but migrate towards the periphery within a few minutes, while TCR/CD3 complexes stabilize within the central area (Krummel et al., 2000) . Both CD4 and CD8 associate with the PTK p56 lck , and the efficient transport of p56 lck into the cSMAC is a major function of these coreceptors (Holdorf et al., 2002) .
T cell signaling pathways
One of the earliest antigen-induced signaling events is the mobilization of Ca 2+ , which is essential for Th cell activation (Wülfing et al., 1997) . This second messenger activates several cytosolic enzymes, initiating downstream signaling cascades (Berridge, 1993a) . However, antigen stimulation also generates signals through the TCR that antagonize Th cell activation. For example, TCR-mediated signals activate the 3',5'-cyclic adenosine monophosphate (cAMP)-dependent protein kinase, PKA (Laxminarayana and Kammer, 1996; Skalhegg et al., 1992) . PKA initiates a signaling pathway that inhibits antigen-induced T cell proliferation and cytokine production (Paliogianni et al., 1993; Vang et al., 2001) . Therefore, to achieve full activation of Th cells, TCR-mediated signals must be modified. We have recently identified signaling pathways induced by MHC class II engagement of CD4. These TCR-independent signals participate in the regulation of intracellular concentrations of both Ca 2+ and cAMP (Zhou and König, 2003) .
Calcium mobilization
The TCR-induced signal transduction leads to the activation of PLCγ1 (Figure 1) . Binding of IP 3 to its receptor in the membrane of the endoplasmic reticulum induces the release of Ca 2+ into the cytosol (Corado et al., 1990) . The subsequent increase in intracellular free Ca 2+ opens Ca 2+ -regulated Ca 2+ channels in the plasma membrane, inducing additional Ca 2+ influx (Berridge, 1993b; Tsien et al., 1982) . Intracellular free Ca 2+ acts as an essential second messenger for T cell activation (Weiss et al., 1984) . Its regulatory effects on T cell activation are mediated via calmodulin, a Ca 2+ -binding protein expressed in all eukaryotic cells (Zhang et al., 1998) . Effective T cell activation leading to IL-2 secretion requires that intracellular Ca 2+ levels be elevated for a period of 1-2 h (Karttunen and Shastri, 1991; Negulescu et al., 1994) . Sustained Ca 2+ signaling is required for maintaining the transcription factor "Nuclear Factor of Activated T cells" (NFAT) in the nucleus in an active form (Loh et al., 1996; Timmerman et al., 1996) . NFAT is a key transcriptional regulator of the IL-2 gene (Rooney et al., 1995) (Figure 3) . Ca 2+ signaling is required for various lymphocyte activities, for example cell motility is impeded by increases in Ca 2+ (Donnadieu et al., 1994; Negulescu et al., 1996) . Increases in Ca 2+ cause changes in the cytoskeletal structure (Wülfing and Davis, 1998) , induce cell death in immature thymocytes (Andjelic et al., 1993) , differentiation (Sloan-Lancaster et al., 1997), and activation (Gearing et al., 1985) . Thus, a single second messenger can elicit multiple cellular responses. The type of response induced may depend on the amplitude, duration, and temporal fluctuations of Ca 2+ mobilization. For example, activation of NF-κB is induced by high levels of Ca 2+ , because of this transcription factor's low Ca 2+ sensitivity. In contrast, even low elevations of Ca 2+ levels, if maintained over a prolonged period of time, selectively activate NFAT, because NFAT is highly sensitive to Ca 2+ but is rapidly inactivated after Ca 2+ removal (Dolmetsch et al., 1997) .
Cyclic AMP, adenylyl cyclases, and cyclic nucleotide phosphodiesterases Cyclic AMP has been defined as an intracellular second messenger to a wide variety of hormones and neurotransmitters. In T cells, numerous studies have shown that elevated cAMP levels antagonize T cell activation. In addition to inhibiting T cell proliferation (Lingk et al., 1990) , cAMP suppresses the production of IL-2 and IFN-γ in activated Th cells (Zidek, 1999) . Opposite effects on IL-5 production from activated Th cells have been observed in different studies (Staples et al., 2000) . TCR signaling alone elevates adenylyl cyclase (AC) activity and intracellular cAMP (Feuerstein et al., 1996) . Importantly, TCRindependent signals induced by CD4 engagement regulate cAMP levels (Zhou and König, 2003) . In T cells, the cAMP level is controlled by two types of enzymes: ACs and cyclic nucleotide phosphodiesterases (PDEs). ACs catalyze the production of cAMP from ATP, whereas PDEs control the rate of cAMP degradation to AMP. At least eleven families of PDEs have been classified by their primary sequences, substrate specificities, susceptibility to selective inhibitors, and tissue location (Manganiello et al., 1995; Soderling and Beavo, 2000) . Among them, PDE families 1,3,4, and 7 have been found in T cells (Ekholm et al., 1997; Giembycz et al., 1996; Hurwitz et al., 1990) . The activity of each of these four families is controlled by distinct mechanisms. The PDE1 family is stimulated by Ca 2+ /calmodulin (Charbonneau et al., 1991) . The PDE3 family is inhibited by cyclic GMP (Tang et al., 1997) . Activation of the PDE4 family has been linked to different pathways. In 3T3-F442A fibroblasts, PDE4 activity is induced by stimulation of p70S6 kinase (Mackenzie et al., 1998) , whereas in FDCP2 myeloid cells, PDE4 is activated via MAP kinase-dependent pathways 8 König and Zhou (Ahmad et al., 1999) . In T cells, CD3 and CD28-mediated signals activate the PDE7 family (Li et al., 1999) .
Elevation of cAMP has long been regarded as inhibitory to T cell activation (Figures 3 and 4) . However, inhibition of basal PKA I activity leads to decreased TCR-triggered IL-2 production (Sugiyama et al., 1997; Zhou and König, 2003) . Also, purified human T cells stimulated by mitogens transiently up-regulate AC and PDE activities with different kinetics for different PDE isozymes (Kanda and Watanabe, 2001 ). Both observations suggest a requirement of cAMP for T cell activation. We have recently demonstrated that cAMP is required for cell cycle progression and cytokine gene expression following antigenic activation of Th cells (Zhou and König, 2003) . Thus, a precise kinetic regulation of the intracellular cAMP concentration is required for Th cell activation.
Cyclic AMP-dependent kinase
The second messenger, cAMP, activates a class of cyclic nucleotide-gated ion channels. It also directly activates the guanine-nucleotide-exchange factors Epac1 and Epac2, which are able to activate Rap1 by promoting its release of GDP and binding to GTP (De Rooij et al., 1998; Kawasaki et al., 1998) . Rap is a small Ras-like GTPase that can suppress the oncogenic transformation of cells by Ras. It is also involved in other cellular activities, including cell differentiation, T cell anergy, and platelet activation (Boussiotis et al., 1997; Franke et al., 1997; York et al., 1998) .
The cAMP-dependent protein kinase, PKA, is the principal intracellular cAMP receptor (Beebe, 1994; Walsh and Van Patten, 1994) . In the absence of cAMP, PKA is an enzymatically inactive, tetrameric holoenzyme, consisting of two catalytic subunits and two regulatory subunits. The cooperative binding of four cAMP molecules to two sites on each regulatory subunit drastically decreases the binding affinity between regulatory and catalytic subunits, and induces dissociation into dimeric regulatory and two monomers of catalytic subunits (Doskeland et al., 1993) . Once freed from the regulatory subunits, the catalytic subunits display serine/threonine kinase activity (Houge et al., 1990) .
PKA I, but not PKA II, mediates the inhibitory role of cAMP on T cell proliferation induced by TCR signaling (Aukrust et al., 1999; Skalhegg et al., 1992) . PKA I antagonizes T cell activation at multiple levels (Chen and Rothenberg, 1994; Ramstad et al., 2000; Van Oirschot et al., 2001; Vang et al., 2001) , one of which is to activate the protein tyrosine kinase, Csk (Vang et al., 2001) . Csk inhibits Lck activity (Abraham and Veillette, 1990) . By inhibiting Lck, PKA I can diminish T cell activation at the initiation stage. This suggests that at the early stage of T cell activation, PKA I activity needs to be restricted. PKA I also phosphorylates Raf-1 to block the MAP kinase pathway (Ramstad et al., 2000) (Figures 2 and 3) . In the nucleus, activation of PKA prevents stable protein-DNA interactions at the NF-κB, NFAT, and AP1 binding sites of the IL-2 enhancer (Chen and Rothenberg, 1994) (Figures 3 and  4) . In addition, PKA I activity also inhibits cyclin D3 expression and induces the cyclin-dependent kinase inhibitor p27 kip1 (Van Oirschot et al., 2001) . For T cells to enter the S phase of the cell cycle, D-type cylins, including cyclin D3, are synthesized during the G 1 phase (Boonen et al., 1999) . These cyclins can bind to cyclin-dependent kinase (Cdk) and form an active kinase complex that phosphorylates and inactivates retinoblastoma protein, pRb (Weinberg, 1995) . Inactivation of pRb then allows cells to pass through the late G 1 phase restriction point and enter the S phase. However, cyclin D/Cdk complexes can associate with the Cdk inhibitor p27 kip1 , thus rendered inactive Nourse et al., 1994) . Therefore, in addition to induction of cyclin D, downregulation of p27 kip1 is also required for the initiation of T cell proliferation (Boonen et al., 1999; Firpo et al., 1994; Nourse et al., 1994) . Hence, inhibition of cyclin D3 expression and induction of p27 kip1 by PKA I both block T cell cycle progression. Little is known about the distribution of PKA I in activated T cells. The only study reported so far demonstrated co-localization of the PKA I holoenzyme with the TCR/CD3 complex in human peripheral blood T cells after crosslinking with anti-CD3 mAb for 30 min (Skalhegg et al., 1994) .
Functional consequences of CD4 engagement by MHC class II
Interactions between CD4 and MHC class II increase antigen-induced Th cell proliferation and cytokine production. Initially, it was thought that CD4 functioned as an adhesion molecule, enhancing contact between Th cells and APCs (Gay et al., 1987) . However, CD4 and MHC class II interact with extremely low affinity (Weber and Karjalainen, 1993; Xiong et al., 2001) , and soluble CD4 does not affect the binding of soluble antigen/MHC class II complexes to immobilized TCR (Xiong et al., 2001) . Furthermore, CD4-MHC class II interactions do not increase the binding avidity between Th cells and APCs (Hamad et al., 1998; Metz et al., 1997; Zhou and König, 2003) . Thus, an adhesive effect of CD4 is unlikely, and the major function of CD4 may be its active participation in Th cell signaling (Sleckman et al., 1991; Zhou and König, 2003) .
Role of CD4 in modulating T cell signal transduction Experiments in our laboratory suggest that CD4-mediated signals facilitate Th cell activation by two mechanisms ( Figure 5 ). First, engagement of CD4 by MHC class II induces increased Ca 2+ mobilization from intracellular stores. This CD4-induced Ca 2+ signal synergizes with the TCR-mediated Ca 2+ signal, thereby allowing the sustained activation of Ca 2+ -regulated membrane Ca 2+ channels and promoting a sustained rise in intracellular free Ca 2+ (Zhou and König, 2003) . A long-lasting elevation of Ca 2+ is required for effective Th cell activation (Rabinowitz et al., 1996; Wulfing et al., 1997) . Second, CD4 signaling counteracts the TCR-mediated increases in cAMP (Zhou and König, 2003) . The CD4-mediated signals activate cAMP PDEs and inhibit AC. TCR signaling in the absence of additional, modifying signals results in the accumulation of cAMP in the cytosol and thus, in partial Th cell activation without the induction of efficient proliferation and cytokine production (Feuerstein et al., 1996; Zhou and König, 2003) . An important characteristic for effective regulation of intracellular cAMP by CD4 signaling is the temporal and spatial sequence of CD4 localization in the signaling synapse. Recruitment of CD4 depends on binding of the TCR to its specific antigen/MHC class II ligand (Krummel et al., 2000) . Thus, an initial TCR-mediated increase in AC activity may be countered by CD4-mediated AC inhibition and PDE activation to promote early T cell activation events. Exclusion of CD4 from the central TCR cluster to the periphery of the signaling synapse within a few min after the initial Ca 2+ signal (Krummel et al., 2000) may then remove the block on cAMP increases to promote proliferation and cytokine production.
The activities of ACs are controlled by hormones, neurotransmitters, chemotactic transducers, and other molecules. A common mechanism to inhibit AC activity is through the activation of G i proteins (e.g., G i1 , G i2 , and G i3 ), which are coupled to receptors for effector molecules. Members of the G i family of proteins positively regulate T cell activation (Lippert et al., 2000) . A 32-kDa GTP-binding protein associates with CD4 and CD8 in human T cell lines (Telfer and Rudd, 1991) . Therefore, inhibition of AC by CD4-MHC class II engagement may be mediated via G i proteins. CD4 may serve as a docking protein, carrying G i proteins to the signaling synapse in activated Th cells, similar to the mechanism by which CD4 promotes p56 lck function (Holdorf et al., 2002) . Therefore, we propose that transduction of costimulatory signals induced by MHC class II engagement represent a major function of the CD4 coreceptor and that CD4-mediated signals participate in the precise regulation of intracellular levels of cAMP following T cell stimulation.
Role of CD4 in regulating T cell homeostasis
We have recently reported that coreceptor interactions with MHC molecules also regulate peripheral T cell homeostasis and the survival of naïve T cells in the absence of antigenic stimulation (König, 2002; König et al., 2002) . We discovered this function of CD4 in a transgenic mouse strain that we generated for the purpose of elucidating the role of CD4 engagement by MHC class II in thymic selection and peripheral activation of Th cells. These transgenic mice express mutant MHC class II molecules defective in their ability to engage CD4 (Gilfillan et al., 1998) . Despite the inability of the mutant MHC class II expressed on thymic epithelial cells to interact with CD4, positive thymic selection into the CD4 lineage proceeds, and CD4 + thymocytes mature. However, levels of single-positive CD4 + thymocytes in these mice are less than one third of those in normal mice. Furthermore, peripheral, naïve CD4 + T cells undergo apoptosis at an approximately three-fold higher rate in mutant MHC class II transgenic mice than do CD4 lineage cells in normal mice (Maroto et al., 1999) . The increased frequency of apoptotic cells is due to a lack of CD4-MHC class II interactions in peripheral lymphoid organs, because naïve CD4 + T cells from normal mice adoptively transferred into mutant MHC class II transgenic hosts meet the same fate as do endogenous Th cells (Shen and König, 2001) . Similarly, CD4-deficient T helper lineage cells are apoptosis-prone, and fail to survive after adoptive transfer into irradiated hosts (Strong et al., 2001) . Thus, CD4 lineage T cells require CD4-MHC class II interactions for efficient positive selection in the thymus and for maintenance of homeostasis in the periphery. Following the selection in the thymus for cells with TCRs that appropriately recognize self-MHC/peptide ligands, a peripheral recertification process enhances the stringency for proper matching between TCR restriction and coreceptor recognition of MHC (König et al., 2002) . This process depends on signals through CD4 (Shen and König, 2001; Strong et al., 2001) .
At the present time, we do not know whether the defect in peripheral Th cell homeostasis in the absence of CD4 engagement by MHC class II is related to an impaired regulation of intracellular cAMP levels. However, this is an attractive hypothesis and future research is targeted towards answering this question.
Outlook
The receptors that induce T cell signaling and the intracellular proteins mediating specific signal transduction pathways have been mostly identified. It is evident that signalosomes in T cells differ in composition depending on the extracellular signal received and the requirements of the stimulated cell. Depending on the level of participation of coreceptors in the induction and modulation of signaling pathways, the composition of established signalosomes may change over time in order to permit the fine-tuning of effector signaling pathways. Future research will focus on determining the kinetics of assembly, the dynamics of composition, and the compartmentalization of components of signalosomes induced during T cell activation. An important aspect will also be to define the interactions between different signaling pathways.
A clear understanding of Th cell signaling will provide a blueprint for the rationale intervention in multiple immune effector functions. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4 + T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. Eur J Immunol 24: 2646-2652. Jauliac, S., Mazerolles, F., Jabado, N., Pallier, A., Bernard, F., Peake, J., Fischer, A., and Hivroz, C. 1998. Ligands of CD4 inhibit the association of phospholipase Cgamma1 with phosphoinositide 3 kinase in T cells: regulation of this association by the phosphoinositide 3 kinase activity. Eur J Immunol 28: 3183-3191. Kahn, M., Sugawara, H., Mcgowan, P., Okuno, K., Nagoya, S., Hellstrom, K.E., Hellstrom, I., and Greenberg, P. 1991. CD4 + T cell clones specific for the human p97 melanomaassociated antigen can eradicate pulmonary metastases from a murine tumor expressing the p97 antigen. J. 
